If you google 'health partners formulary search' you will get to their website that has 4 medicaid, 1 minnesota, and 1 medicare formulary search.
Shows that Afrezza was accepted by the formulary committee on 8/25/15 and went into effect on 9/1/2015.
The website was last updated in Oct 2015.
This is big big news folks.
While HP MCare is a less stringent MCare formulary by history, it is a gateway to other MCare insurers.
SNY is clearly doing some work behind the scenes to clear formulary hurdles.
Refill rate for Afrezza continues to impress, as does the social media response which has been overwhelmingly positive.
12U is now available.
Debt has been resolved at nearly 50% cash (as per aegis conference call) and the last cash position in q2 was $107m so we can safely assume that we are in the $60-70m range and have reduced quarterly burn to $12m not including the recent downsizing which should put our burn rate even lower.
With the SNY Line of Credit the company can continue to operate without dilution for at least 12 months and the upcoming milestone achievement that Matt said we have yet to fulfill will eventually add $25m to the coffers and extend us out to 18 months.
Between the other available lines of credit facilities, MNKD can operate without additional financing for the next 3-4 years.
The balance sheet continues to improve remarkably with each quarter.
BOA has presumably returned 9m shares to the company.
The inflection point in the stock should have come in August with the resolution of the debt, but delays have hurt the stock.
Everything is now falling into place. Hopefully by the end of the year we can really see widespread coverage in time for the Superbowl Ad(LOL)
